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HistopathologyAbstract Iron oxide nanoparticles (Fe2O3-IONPs) have revolutionized the industry by significant
economic and scientific impacts. Enormous increase in the usage of IONPs has raised concerns
about their unseen adverse effects. In the current study, we investigated the effects of IONPs and
its bulk on oxidative stress biomarkers, histopathology and biodistribution in rats after 28 days
repeated oral treatment at 30, 300 and 1000 mg/kg body weight (b.w.). IONPs size in dry, wet forms
and crystallinity was determined using TEM, DLS and XRD. The investigation of oxidative stress
biomarkers demonstrated significant increase in lipid peroxidation and decrease in reduced glu-
tathione content in the liver, kidney and the brain of the treated groups in a dose dependant man-
ner. Further, antioxidant enzymes catalase, glutathione S transferase, glutathione peroxidase and
glutathione reductase activities were significantly elevated along with significant decrease in super-
oxide dismutase activity in treated rat organs. ICP-OES analysis revealed dose and size dependant
accumulation of IONPs in the liver followed by kidney and the brain than bulk. Moreover, accu-
mulation of IONPs at high dose brought pathological changes only in liver. A large fraction of
IONPs was eliminated in urine. Bulk material was substantially excreted in faeces than IONPs sug-
gesting increased absorption of IONPs. In conclusion accumulated IONPs and bulk in organs trig-
ger free radical generation, leading to the induction of oxidative stress condition in rats. The results
obtained highlight the importance of toxicity assessments in evaluating the efficiency of IONPs for
the safe implementation for diversified applications.
 2015 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Nanotechnology is the mere controlling and fabrication of
materials at nano scale level, where characteristics vary with
altered size, shape, density, aggregation and surface area. This
technological leap leads to a revolution in the field of electron-
ics and communications, optics, chemistry, energy and biologys. Saudi
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expanding field with an estimated market of $75.8 billion by
2020 (www.reportlinker.com/april2015). IONPs have promis-
ing characteristics like biocompatibility and magnetic beha-
viour that makes them good agents for magnetic resonance
imaging, carriers for drug delivery, magnetic hyperthermia, tis-
sue engineering, cell separation, enzyme immobilization, pro-
tein purification and biosensing (Mahmoudi et al., 2012;
Rosen et al., 2012). IONPs are also used in many analytical
techniques like PCR, immunoassay, HPLC and LC MS/MS
(Cao et al., 2012). Moreover, IONPs offer significant improve-
ments in water purification and environmental remediation
because of low cost technology (Baumann et al., 2014).
New approaches in nanotechnology and extensive produc-
tion for numerous diversified applications of nanomaterials
(NMs) might increase human exposure. A recent study on mice
by Yang et al. (2015), reported size dependent bioaccumulation
and transport of IONPs in the liver and spleen. Further, expres-
sion of genes associated with antioxidant defence system, trans-
port and metabolism of iron were reported when treated with
IONPs. Pregnant mice treated with multiple doses of IONPs
reported biodistribution of iron in the foetal liver, placenta
and increased foetal deaths (Di Bona et al., 2014). Intratracheal
instillation studies of IONPs in mice reported increased cell dis-
ruption in the respiratory epithelium and affected haemostasis
(Zhu et al., 2008). Initiation of microglial proliferation and
pathological alterations in the brain was observed in mice trea-
ted with IONPs by intranasal route (Wang et al., 2011). IONPs
induced higher levels of inflammation and immunosuppression
in mice (Ban et al., 2013). This shows that IONPs can easily
cross the intestinal lining and can enter into systemic circula-
tion where it accumulates in different organs.
In vivo and in vitro studies of different NMs reported gen-
eration of free radicals and oxidative injury is the key mecha-
nism to instigate adverse effects on cellular functions (Auffan
et al., 2009). Overloading of cells with IONPs may trigger
inimical cellular effects by initiating the fenton chemistry,
which generates free radicals (Singh et al., 2009). Cells have
antioxidant defence system to intercept the reactive oxygen
species (ROS), however if the biological systems fail to nullify
the overwhelming ROS, it will lead to oxidation of biomole-
cules like proteins, DNA and lipids (Prabhakar et al., 2012).
Several studies demonstrated oxidative stress as an important
biomarker in assessing NMs toxicity (Jain et al., 2008; Park
and Park, 2009; Prabhakar et al., 2012; Negahdary et al.,
2015; Arooj et al., 2015).
In the present investigation, the physicochemical properties
of IONPs were determined using X-ray Diffraction (XRD),
Transmission Electron Microscopy (TEM) and Dynamic Light
Scattering (DLS). The purpose of the current study was to
assess the differences in exerting toxic effects between IONPs
and bulk after repeated oral treatment to Wistar rats. The
liver, kidney and the brain were selected for our study, to
investigate the oxidative stress induced by IONPs and its bulk
using biomarkers like reduced glutathione (GSH), malondi-
aldehyde (MDA), antioxidant enzymes catalase (CAT), super-
oxide dismutase (SOD), glutathione peroxidase (GPx),
glutathione reductase (GR) and glutathione S transferase
(GST). The histopathological analysis was done to detect tis-
sue damage, if any. Biodistribution studies were undertaken
to identify the potential target site of accumulation of IONPs
and bulk.Please cite this article in press as: Reddy, U.A. et al., Biomarkers of oxidative stress
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2.1. Materials
Fe2O3-bulk materials size of <5 lm (CAT #310050, purity
P99%), iron standard (CAT #43149) and all chemicals were
purchased from Sigma Aldrich Inc., USA.2.2. Synthesis and characterization of IONPs
IONPs were produced by chemical coprecipitation method fol-
lowing the method of Lee et al. (2004). The purity of IONPs
was performed according to the method given by Yokel
et al. (2009). The spectra analysis of IONPs was obtained using
Siemens/D-5000 X-ray diffractometer. The size and morphol-
ogy of IONPs were characterized using TEM (Hitachi H-
7600). Hydrodynamic size distribution and zeta potential of
IONPs were measured using Malvern Zetasizer. Probe sonica-
tor (UP100H Heilscher, Germany) was used to disperse the
NMs. Dispersion of NMs in the solution is measured by the
polydispersity index (PDI).2.3. Animals and treatment
According to the OECD (Organization for Economic Cooper-
ation and Development) guidelines, the preferred rodent spe-
cies is the rat, preferably females because of their sensitivity
in comparison to males. Hence, female rats were used in our
study. Institutional Animal Ethics Committee (IICT, Hyder-
abad) approved the present investigation. Female albino wistar
rats of 8–10 weeks were procured from the National Institute
of Nutrition, Hyderabad, India. Animals were acclimatized
under standard laboratory conditions for 7 days prior to the
start of experiments. The animals were fed on commercial pel-
let diet and water ad libitum.
The animals were randomly selected, marked and divided
into following groups:foGroupr in vivo assessment of toxCompoundicological eﬀects of iron oxideDosageControl Water –Low Nano 30 mg/kg b.w.Medium Nano 300 mg/kg b.w.High Nano 1000 mg/kg b.w.Low Bulk 30 mg/kg b.w.Medium Bulk 300 mg/kg b.w.High Bulk 1000 mg/kg b.w.The rats were treated daily with IONPs and bulk for 28 days
and sacrificed on the 29th day after being anesthetized. The
study and dose design were according to OECD guideline
407 (2008). High dose was chosen to illustrate the lethal effects
and symptoms without mortality, whereas the low dose was
selected to demonstrate no observed adverse effect levels
(NOAEL). The animals were checked for toxic symptoms
and mortality (if any) every day, whereas, weight gain and feed
intake were recorded once in a week.nanoparticles. Saudi
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Lipid peroxidation (LPO) in rat organs was estimated accord-
ing to the method described by Wills (1969); reduced glu-
tathione (Jollow et al., 1974); superoxide dismutase
(Marklund and Marklund, 1974); catalase (Aebi, 1984); glu-
tathione peroxidase (Paglia and Valentine, 1967); glutathione
reductase (Carlberg and Mannervik, 1985); glutathione S
transferase (Habig et al., 1974) and detailed procedures were
described in Reddy et al. (2015). The protein estimation was
done using Lowry et al. (1951) method.
2.5. Analysis of iron content in tissues
A part of the liver, kidney, and the brain from each group was
collected at the end of the study. Individual urine and faecal
samples were collected daily and pooled, analysed for the metal
content following standard procedures as described in our ear-
lier publication Reddy et al. (2015). ICP-OES (IRIS Intrepid II
XDL, Thermo Jarrel Ash) was used to quantify Fe concentration
at alternate wavelengths (232 nm and 238 nm). Quantification of
Fe was done using a calibration curve.
2.6. Histopathological study
The liver, kidney and the brain collected from each rat were
fixed in 10% formalin and processed following standard proce-
dures. Detailed protocol was described in Reddy et al. (2015).Figure 1 Characterization of IONPs by (A) XRD, (B
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All the data were expressed as mean ± standard deviation
(SD). Graphpad prism 5, a statistical software system
was used to perform a post hoc multiple comparison test
(Dunnet’s test) after ANOVA. P< 0.05 was considered to
be significant.3. Results
3.1. Characterization
Fig. 1 summarizes the characterization of IONPs by XRD,
TEM and DLS. The purity analysis by ICP-OES revealed that
the purity of IONPs was >96%. This analysis was in support
of XRD data obtained. Peaks obtained signify size, purity and
crystallinity of IONPs and revealed similar characteristics with
c-Fe2O3. TEM characterization of IONPs showed spherical
morphology with mean size distribution of 7.02 ± 1.58 nm.
The hydrodynamic sizes of IONPs were measured using DLS
in MilliQ water showed an average diameter of 155 nm with
a PDI measurement of 0.526. These hydrodynamic sizes in dis-
persion vehicle were larger than their original size in powder
form signifying nanoparticles agglomeration. Zeta potential
measurements for IONPs were 29.9 mV at pH 7. For bulk
material size distribution intensity was found to be beyond
detection limits.) TEM, (C) size distribution and (D) zeta potential.
for in vivo assessment of toxicological eﬀects of iron oxide nanoparticles. Saudi
4 U.A. Reddy et al.3.2. Morphology, feed intake and body weight of animals
Fig. 2 represents body weight (A) and feed intake (B) of ani-
mals treated with IONPs and bulk. Signs of toxicity and mor-
tality were not seen in the treated rats. However, rats treated
with a high dose of bulk and IONPs showed significant loss
in body weight in weeks 3 and 4. Average feed intake per ani-
mal was significantly decreased in high dose IONPs treated
rats in comparison to other treatment groups and control.3.3. Oxidative stress biomarkers
The effect of IONPs and bulk on LPO in the liver, kidney and
the brain is presented in Fig. 3A. IONPs and bulk treatment
caused significant and a dose dependent increase in MDA
levels in the liver at high and medium doses. Only high dose
of IONPs and bulk increased LPO level in kidney and theFigure 2 (A) Effect of IONPs and its bulk on body-weight profile. (B
represents the mean ± SD; n= 5 rats.
Figure 3 MDA (A) and GSH (B) levels in rats treated with IONPs a
rats. *P< 0.05.
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the bulk. The changes in GSH content in different tissues of
treated and control rats are summarized in Fig. 3B. IONPs
and bulk brought dose dependent depletion in GSH content
of the liver, except low dose group of bulk material. However,
IONPs at 1000 mg/kg b.w. and 300 mg/kg b.w. and bulk at
1000 mg/kg b.w. significantly decreased GSH content in kid-
ney and the brain. Furthermore, depletion in GSH content
was found high in IONPs treated rats than its bulk. High
and medium dose of IONPs and bulk treatment caused signif-
icant and dose dependent inhibition of SOD in liver. However,
1000 mg/kg b.w. treatment of IONPs and bulk caused deple-
tion in SOD activity in kidney and the brain(Fig. 4A). A signif-
icant and dose dependant elevation in activity of CAT was
observed in the liver, when rats were treated with IONPs
and bulk at 1000 mg/kg b.w. and 300 mg/kg b.w. Similarly sta-
tistically significant increase in CAT activity was observed in
kidney and the brain after the treatment of IONPs and bulk) Effect of IONPs and its bulk on feed intake profile. Each value
nd bulk for 28 days. Each value represents the mean ± SD; n= 5
for in vivo assessment of toxicological eﬀects of iron oxide nanoparticles. Saudi
Figure 4 Effect of 28 day oral treatment of IONPs and Bulk on antioxidant enzyme activities in rat organs. Each value represents the
mean ± SD; n= 5 rats. *P< 0.05.
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6 U.A. Reddy et al.at 1000 mg/kg b.w. (Fig. 4B). IONPs and bulk treatment at
1000 mg/kg b.w. elevated GPx activity significantly only in
the liver and kidney. The activity of GPx was not altered in
the brain at all the doses of IONPs and bulk treatment
(Fig. 4C). GR activity was significantly elevated in the liver
in a dose dependent manner after IONPs treatment at
300 mg/kg b.w. and 1000 mg/kg b.w. However, bulk treatment
at 1000 mg/kg b.w. increased GR activity only in the liver.
Further, significant change in activity of GR was observed in
kidney and the brain at mg/kg b.w. of IONPs and bulk treat-
ment (Fig. 4D). Treatment of IONPs and bulk at 1000 mg/kg
b.w. caused a substantial increase in GST activity in the liver,
kidney and the brain (Fig. 4E). Antioxidant enzymes SOD,
CAT, GPx, GR and GST were modulated significantly in
IONPs treated rats than its bulk.
3.4. Analysis of iron content in tissues
A dose dependant increase in accumulation of Fe content was
seen in the liver (188 lg/g, 224 lg/g, 303.9 lg/g), followed by
kidney (58.8 lg/g, 67.4 lg/g, 88 lg/g) and the brain (28.6
lg/g, 38.3 lg/g, 45.8 lg/g) in IONPs treated rats. Similarly
uptake of bulk was high in the liver (151.5 lg/g, 178.5 lg/g,
191.2 lg/g) followed by kidney (49.2 lg/g, 57.3 lg/g, 65.2 lg/g)
and the brain (28 lg/g, 30.8 lg/g, 37.5 lg/g). However, accu-
mulation of IONPs in organs was higher than bulk. Elimina-
tion of Fe through urine was found to be more significant in
IONPs (65.3 lg/ml, 74.6 lg/ml, 83.6 lg/ml) treated group than
bulk (51.2 lg/ml, 59.2 lg/ml, 68.3 lg/ml). In contrary, in faeces
bulk (2390 lg/g, 8849.7 lg/g, 11072.4 lg/g) was eliminated
more in comparison to IONPs (1116.7 lg/g, 3233.5 lg/g,
5366.9 lg/g) as shown in Fig. 5A.Figure 5 Metal content analysis in tissues of treated rats after 28 da
represents the mean ± SD; n= 5 rats. *P< 0.05.
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The histopathological changes in IOPNs and bulk treated the
liver, kidney and the brain are presented in Fig. 6. Only high
dose treatment of IONPs caused congested portal tract in liver
whereas, normal histology was observed in the remaining
groups of IONPs and bulk.4. Discussion
Nanotoxicological studies performed in vivo using different
routes of exposure hold greater impact in evaluating the
adverse biological effects. In the present investigation, we
hypothesized oxidative stress as a crucial parameter in IONPs
induced toxicity in treated rats. The current study illustrates
that the MDA levels were increased in tissues in a dose depen-
dent manner in both IONPs and bulk treated rats. Elevated
levels of MDA indicate the formation of hydroxyl radicals
which in turn is associated with LPO of tissues. Our results
illustrated a dose dependent depletion of reduced glutathione
(GSH) after IONPs and bulk treatment, possibly due to
enhanced utilization of GSH in both enzymatic and non-
enzymatic reactions. Srinivas et al. (2012) reported elevated
LPO and depleted GSH in rat lung tissue after inhalation
exposure of IONPs. Similarly, oral toxicity study of aluminium
oxide NMs and bulk demonstrated elevated levels of MDA
and decreased GSH levels in a dose dependant manner in
the liver, kidney and the brain of treated rats (Prabhakar
et al., 2012). Hence, it is suggested that MDA and GSH con-
tents are good biomarkers in assessing toxicity, which may
be possibly due to free radical generation.ys repeated treatment with IONPs and bulk material. Each value
for in vivo assessment of toxicological eﬀects of iron oxide nanoparticles. Saudi
Figure 6 Photomicrographs of various organs of rats after 28 day repeated oral treatment with IONPs and bulk material. Upper panel
represents normal architecture of the liver, kidney and the brain from control rats. Lower panel represents the liver, kidney and the brain
from high dose group treated with IONPs, congested portal tract in the liver pointed by arrow. Observation was made at 40
magnification.
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counter act oxidant insult. In this study, a significant increase
in CAT, GR, GPx, GST and decrease in SOD activity in trea-
ted rat tissues were observed. Superoxide radicals in associa-
tion with adventitious metal like Fe, triggers the oxidative
damage of proteins, lipids and nucleic acids (Chevion, 1988).
Current study revealed a dose dependent decrease in SOD
activity in rat organs. This might probably be due to the heavy
influx of superoxide radicals that in turn resulted in high levels
of H2O2 generation, which subsequently inhibited SOD activ-
ity (Li et al., 2010b). IONPs and bulk treatment caused eleva-
tion in enzyme kinetics of CAT as a defensive mechanism
against excess H2O2 levels. GPx initiates H2O2 breakdown
only at low concentrations, whereas CAT needs high levels
of H2O2 to commence its activity. An increased GR activity
was found in our study, this result reflects the recycling of oxi-
dized GSH to reduced GSH by the pro-oxidant system which
involves a coupled reaction engaged by GR (Nordberg and
Arne´r, 2001). Elevated GST activity and depleted GSH levels
suggest increased utilization of GSH in conjugation reactions
as part of detoxification mechanism. Altered antioxidant status
as reported in our study is supported by findings from other
investigations. Prabhakar et al. (2012) reported increased
enzyme activities of CAT and GST, with depleted SOD activ-
ity in rat tissues exposed to aluminium oxide NMs. Adminis-
tration of TiO2 NMs to mice for 14 days induced significant
oxidative stress than its bulk (Ma et al., 2010). An altered
antioxidant status revealed imbalance in oxidant and antioxi-
dant levels in the tissues.
In the present study ICP-OES analysis revealed that IONPs
and bulk material were absorbed and extensively deposited inPlease cite this article in press as: Reddy, U.A. et al., Biomarkers of oxidative stress
Journal of Biological Sciences (2015), http://dx.doi.org/10.1016/j.sjbs.2015.09.029the liver, kidney and the brain, and excreted through urine and
faeces. Wang et al. (2010) reported accumulation of IONPs in
major systemic organs of mice at an oral dose of 600 mg/kg b.
w., which is in support of our results. In the current investiga-
tion, IONPs with a hydrodynamic size of 155 nm and with a
charge of 29.9 mV were readily taken by liver for phagocyto-
sis, which clearly indicates size and charge also influence the
uptake and clearance mechanisms. Our results demonstrated
that uptake of IONPs was more in the liver, kidney and the
brain in a dose dependent manner. The IONPs have differen-
tial organ distribution pattern which seems to be influenced by
Fe binding proteins like transferrin and ferritin, which serve as
carrier of Fe to different tissues. Increased Fe levels in brain in
the present investigation might be due to binding of Fe to
transferrin, that triggers up regulation of Fe receptors in the
brain, thus transporting Fe across the blood brain barrier
(Descamps et al., 1996). Inhalation exposure study in mice
demonstrated that IONPs <50 nm reached the brain without
provoking any adverse effects (Kwon et al., 2008). Higher
localization of IONPs in liver might have caused histopatho-
logical changes, causing congestion in portal tract. However,
histological changes were not observed in kidney and the brain
of both the treated groups. A dose dependant and significant
amount of IONPs was eliminated in urine. Trace amount of
bulk passed through the intestinal epithelium and remaining
being excreted in faeces. However, IONPs excreted in faeces
were less than the bulk.
Taken together, the findings from the current investigation,
confirm that IONPs accumulation in tissues triggered ROS
generation, which significantly altered the antioxidant enzyme
levels. The altered antioxidant status and bioaccumulation offor in vivo assessment of toxicological eﬀects of iron oxide nanoparticles. Saudi
8 U.A. Reddy et al.IONPs caused histomorphological changes, which demon-
strate that increase in oxidative stress affects the cellular struc-
ture. Moreover, the results of this study can be utilized by the
regulatory bodies in defining safety limits for the usage of
IONPs in biomedical applications.
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